Turtle Cameron 4
4 · Spyre Therapeutics, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Turtle Cameron
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-01+277,750→ 277,750 totalExercise: $25.86Exp: 2034-02-01→ Common Stock (277,750 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 277,750 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.